Updated just now · Live
Stock analysis, price data, and AI-powered insights for Pacific Biosciences of California Inc (PACB).
Pacific Biosciences of California Inc operates in the Life Sciences Tools & Services sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for PACB.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). PACB Stock Intelligence Report. [stoxpulse.com/stocks/pacb]
Disclaimer: The information on this page about Pacific Biosciences of California Inc (PACB) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Pacific Biosciences of California Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
PacBio and Lucid Genomics Announce Compatibility C...
5h ago
PacBio to Report First Quarter 2026 Financial Resu...
4d ago
StoxPulse AI results for PACB: Pulse Score 52.5/100. Primary sentiment trends from 4 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$525.5M
P/E Ratio
—
EPS
$-0.13
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing
PacBio to Report First Quarter 2026 Financial Results on May 7, 2026
PacBio and Covaris Announce Joint Workflow Enabling HiFi Sequencing of FFPE Tumor Samples
PacBio And PerkinElmer Subsidiary Covaris Announce That A Joint Workflow Has Been Developed For Robust HiFi Sequencing Of Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue Samples